13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SC Filed 2021-03-31 Event — SEC 0001193125-21-102547 →

QVT Financial LP → MP Materials Corp. / DE MP

Stake: — Shares: —
Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 21/100 · Filer 90d Win Rate: 100% · Hist. 90d Edge: +29.9%
  • Passive Schedule 13G filer baseline
  • Elevated short days-to-cover (6.2 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
3 transactions
1 buys · 2 sales · 0 awards/exercises
Issuer Cluster
7 13D/G filings on this issuer
6 other filings besides this one
Filer Track Record
10 filings by this filer
9 other filings in the data moat
Short Interest · settle 2026-10-15
DTC 6.20
36,236,316 shares short · -1.1% vs prior

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-09-30 DUCKWORTH CONNIE K director Award 740 — —
2026-04-20 Litinsky James H. director, officer Sale 259,179 $64.03 $16.60M
2026-04-17 Litinsky James H. director, officer Sale 40,821 $64.05 $2.61M

Other 13D/G Filings on MP Materials Corp. / DE

FiledFormFilerStakeShares
2026-01-13 SCHEDULE Litinsky James H. 7.30% 13,022,362 view →
2023-05-31 SC Litinsky James H. — — view →
2022-03-02 SC JHL Capital Group LLC — — view →
2021-09-20 SC QVT Financial LP — — view →
2021-09-20 SC JHL Capital Group LLC — — view →
2021-03-30 SC JHL Capital Group LLC — — view →

Other Filings by QVT Financial LP

FiledFormIssuerStakeShares
2026-08-26 SCHEDULE 13D/A Allot Ltd. 11.72% 5,734,812 view →
2025-02-28 SCHEDULE Allot Ltd. ALLT 9.05% 3,555,793 view →
2021-09-20 SC MP Materials Corp. / DE MP — — view →
2019-07-12 SC Urovant Sciences Ltd. — — view →
2019-07-12 SC Axovant Gene Therapies Ltd. — — view →
2019-07-12 SC Myovant Sciences Ltd. — — view →
2019-07-12 SC Arbutus Biopharma Corp ABUS — — view →
2019-03-19 SC Axovant Sciences Ltd. — — view →
2018-01-16 SC Arbutus Biopharma Corp ABUS — — view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →